Further Information
NTRK2, neurotrophic tyrosine kinase, receptor, type 2, GP145-TrkB, TRKB , BDNF/NT-3 growth factors receptor, tyrosine kinase receptor B, BDNF receptor
Peptide ELISA: antibody detection limit dilution 1:64000.Western Blot:Approx 100kDa band observed in Human Brain (Hippocampus, Cerebral Cortex and Cerebellum) lysates (calculated MW of 93.8kDa according to NP_006171.2). Recommended concentration: 0.05-0.2ug/ml.
- Hashimoto T, Bergen SE, Nguyen QL, Xu B, Monteggia LM, Pierri JN, Sun Z, Sampson AR, Lewis DA. Relationship of brain-derived neurotrophic factor and its receptor TrkB to altered inhibitory prefrontal circuitry in schizophrenia.
Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
Aliquot and store at -20?C. Minimize freezing and thawing.
500 ug/mL
Unconjugated
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
Expected Species Reactivity based on sequence homology: Mouse, Rat, Dog
The immunogen for this antibody is: C-KTLQEAKSSPDTQ
4915
neurotrophic tyrosine kinase, receptor, type 2
NTRK2
Homo sapiens
Liquid
PREDICTED MOLECULAR WEIGHT:
Approx 100kDa
NP_006171.2, NP_001007098.1, NP_001018074.1, NP_001018075.1, NP_001018076.1
2497560
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Obesity,Signal Transduction,Obesity Signal Transduction
This antibody is expected to recognise isoforms a (NP_006171.2), b ((NP_001007098.1), c (NP_001018074.1), d (NP_001018075.1), e ( NP_001018076.1).
Q16620